Source: iQoncept / Shutterstock
Agile Therapeutics (NASDAQ:AGRX) just reported results for the first quarter of 2024.
- Agile Therapeutics reported earnings per share of -63 cents. This was below the analyst estimate for EPS of -51 cents.
- The company reported revenue of $5.72 million.
- This was 52.43% better than the analyst estimate for revenue of $3.75 million.
Article printed from InvestorPlace Media, https://investorplace.com/earning-results/2024/05/agrx-stock-earnings-agile-therapeutics-for-q1-of-2024/.
©2024 InvestorPlace Media, LLC